"半导体生产环境的洁净标准，丝毫不亚于医院手术室。我们的技术迁移已经到了关键阶段，资金及时 到位，相当于给项目按下了'加速键'！"在电子洁净工程试验车间内，华康洁净相关负责人注视着调试 中的设备，对前来回访的兴业银行武汉分行服务团队感慨道。 深耕医疗净化领域17年，武汉华康世纪洁净科技股份有限公司早已是行业内的"标杆缔造者"——近三年 在医疗专项板块中标量持续领跑行业，打造的"华西系""浙大系"等百家顶尖医院案例成为业界范本，并 先后承接了6个国家级、省级重点实验室及10位院士实验室的净化工程，在医疗洁净领域构筑起坚实的 技术护城河。 随着半导体、新型显示等战略性新兴产业驶入发展快车道，对生产环境的极致洁净要求，催生了电子洁 净工程这片万亿级新蓝海。"我们的核心环境控制技术有跨界复用的基础，但从医疗领域拓展至工业领 域，面临设备升级、团队扩建、市场开拓等多重资金需求。"企业相关负责人坦言。 急企业之所急，赋能转型之所向。兴业银行武汉分行迅速组建跨部门专项服务团队，直奔企业生产经营 一线。从医疗洁净的技术积累到电子洁净的市场蓝图，从短期运营资金到中长期项目投入，团队与企业 进行了多轮深度对接。 "企业转型期的金 ...

12月25日，华康洁净涨5.12%，截至发稿，报44.97元/股，成交4.54亿元，换手率14.54%，总市值48.47 亿元。 招商量化精选股票发起式A（001917）基金经理为王平。 截至发稿，王平累计任职时间15年191天，现任基金资产总规模212.47亿元，任职期间最佳基金回报 271.58%， 任职期间最差基金回报-70.61%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 资料显示，武汉华康世纪洁净科技股份有限公司位于湖北省武汉市东湖新技术开发区高新大道718号3 栋，成立日期2008年11月12日，上市日期2022年1月28日，公司主营业务涉及医疗净化系统研发、设 计、实施和运维,相关医疗设备和医疗耗材的销售。主营业务收入构成为：净化系统集成85.24%，医疗 耗材销售8.53%，医疗设备销售3.74%，运维服务1.88%，其他(补充)0.61%。 从华康洁净十大流通股东角度 数据显示，招商基金旗下1只基金位居华康洁净十大流通股东。招商量化精选股票发起式 ...

Core Viewpoint - Huakang Clean experienced a decline of 3.26% in stock price on December 24, with a trading volume of 670 million yuan, indicating potential volatility in the stock market performance [1] Financing Summary - On December 24, Huakang Clean had a financing buy-in amount of 75.04 million yuan and a financing repayment of 78.03 million yuan, resulting in a net financing buy of -2.99 million yuan [1] - The total financing and securities balance for Huakang Clean reached 152 million yuan, accounting for 3.30% of the circulating market value, which is above the 90th percentile level over the past year, indicating a high financing level [1] - In terms of securities lending, Huakang Clean repaid 100 shares on December 24, with no shares sold, and a remaining securities lending balance of 6,900 shares valued at 295,200 yuan, also above the 90th percentile level over the past year [1] Business Performance - As of December 19, Huakang Clean had 10,700 shareholders, an increase of 3.08% from the previous period, while the average circulating shares per person decreased by 2.99% to 6,802 shares [2] - For the period from January to September 2025, Huakang Clean reported a revenue of 1.431 billion yuan, representing a year-on-year growth of 32.59%, and a net profit attributable to shareholders of 61.16 million yuan, which is a significant increase of 211.46% year-on-year [2] Dividend and Shareholding - Since its A-share listing, Huakang Clean has distributed a total of 40.02 million yuan in dividends, with 29.46 million yuan distributed over the past three years [3] - As of September 30, 2025, new institutional shareholders include Fortune Optimized Enhanced Bond A/B (100035) as the sixth largest shareholder with 1.8 million shares, and Fortune Jiuli Steady Allocation Mixed A (003877) as the ninth largest shareholder with 497,800 shares [3]

Core Viewpoint - Huakang Clean achieved significant revenue growth and profitability in the first nine months of 2025, indicating strong business performance in the medical purification sector [2]. Group 1: Financial Performance - For the period from January to September 2025, Huakang Clean reported operating revenue of 1.431 billion yuan, representing a year-on-year increase of 32.59% [2]. - The net profit attributable to the parent company reached 61.1567 million yuan, showing a substantial year-on-year growth of 211.46% [2]. Group 2: Shareholder and Market Activity - As of October 31, 2025, the number of Huakang Clean's shareholders increased to 10,600, up by 2.43% from the previous period [2]. - The average number of circulating shares per shareholder decreased by 2.37% to 6,845 shares [2]. - On November 6, 2025, Huakang Clean's stock price rose by 0.40%, with a trading volume of 55.2064 million yuan [1]. Group 3: Financing and Margin Trading - On November 6, 2025, Huakang Clean had a financing buy-in amount of 6.5431 million yuan, while the financing repayment was 9.0856 million yuan, resulting in a net financing buy of -2.5425 million yuan [1]. - The total margin trading balance for Huakang Clean reached 98.7520 million yuan, accounting for 3.05% of its market capitalization, which is above the 90th percentile of the past year [1]. - There were no shares sold or repaid in the securities lending market on November 6, 2025, with the securities lending balance also at zero, indicating a high level of inactivity in this area [1]. Group 4: Dividend Distribution - Huakang Clean has distributed a total of 40.0214 million yuan in dividends since its A-share listing, with 29.4614 million yuan distributed over the past three years [3]. Group 5: Institutional Holdings - As of September 30, 2025, new institutional shareholders include Fortune Optimized Enhanced Bond A/B and Fortune Jiuli Steady Configuration Mixed A, which are now among the top ten circulating shareholders [3].

Group 1 - The core viewpoint of the news is that Huakang Clean experienced a decline in stock price, dropping by 5.09% to 31.15 CNY per share, with a trading volume of 160 million CNY and a turnover rate of 6.99%, resulting in a total market capitalization of 3.357 billion CNY [1] - Huakang Clean, established on November 12, 2008, and listed on January 28, 2022, specializes in the research, design, implementation, and operation of medical purification systems, along with the sale of related medical equipment and consumables [1] - The revenue composition of Huakang Clean includes: 85.24% from purification system integration, 8.53% from medical consumables sales, 3.74% from medical equipment sales, 1.88% from operation and maintenance services, and 0.61% from other sources [1] Group 2 - Among the top ten circulating shareholders of Huakang Clean, a fund under China Merchants Fund, specifically the China Merchants Quantitative Selected Stock A (001917), has newly entered the list in the third quarter, holding 470,000 shares, which accounts for 0.65% of the circulating shares [2] - The estimated floating loss for the fund today is approximately 784,800 CNY [2] - The China Merchants Quantitative Selected Stock A fund, established on March 15, 2016, has a latest scale of 3.663 billion CNY, with a year-to-date return of 43.95%, ranking 1030 out of 4218 in its category, and a one-year return of 48.62%, ranking 670 out of 3878 [2]

Group 1 - The core point of the news is that Huakang Clean experienced a decline of 5.42% in its stock price, reaching 33.70 CNY per share, with a trading volume of 53.69 million CNY and a turnover rate of 2.15%, resulting in a total market capitalization of 3.63 billion CNY [1] - Huakang Clean, established on November 12, 2008, and listed on January 28, 2022, is based in Wuhan, Hubei Province, and specializes in the research, design, implementation, and operation of medical purification systems, along with the sale of related medical equipment and consumables [1] - The revenue composition of Huakang Clean includes: 85.24% from purification system integration, 8.53% from medical consumables sales, 3.74% from medical equipment sales, 1.88% from operation and maintenance services, and 0.61% from other supplementary services [1] Group 2 - Among the top ten circulating shareholders of Huakang Clean, a fund under China Merchants Fund, specifically the China Merchants Quantitative Selected Stock A (001917), has newly entered the list in the third quarter, holding 470,000 shares, which accounts for 0.65% of the circulating shares [2] - The China Merchants Quantitative Selected Stock A fund, established on March 15, 2016, has a latest scale of 2.765 billion CNY, with a year-to-date return of 42.35% and a one-year return of 49.25%, ranking 1008 out of 4218 and 673 out of 3876 respectively [2] - The fund manager, Wang Ping, has a cumulative tenure of 15 years and 132 days, with the fund's total asset scale at 16.687 billion CNY, achieving a best return of 282.09% and a worst return of -70.61% during his tenure [2]

Core Insights - Huakang Clean's stock price increased by 5.3% to 34.96 CNY per share, with a trading volume of 95.89 million CNY and a turnover rate of 3.91%, resulting in a total market capitalization of 3.768 billion CNY [1] Company Overview - Wuhan Huakang Century Clean Technology Co., Ltd. is located in the East Lake New Technology Development Zone, Wuhan, Hubei Province, and was established on November 12, 2008, with its listing date on January 28, 2022 [1] - The company's main business involves the research, design, implementation, and operation of medical purification systems, along with the sale of related medical equipment and consumables [1] - Revenue composition: Purification system integration accounts for 85.24%, medical consumables sales 8.53%, medical equipment sales 3.74%, operation and maintenance services 1.88%, and other supplementary services 0.61% [1] Shareholder Insights - Anxin Fund has a presence among Huakang Clean's top ten circulating shareholders, with Anxin Medical Health Stock A (010709) newly entering the top ten in the second quarter, holding 652,800 shares, which is 1.28% of the circulating shares [2] - The estimated floating profit for Anxin Medical Health Stock A today is approximately 1.1489 million CNY [2] - Anxin Medical Health Stock A was established on January 12, 2021, with a latest scale of 442 million CNY, achieving a year-to-date return of 64.37%, ranking 201 out of 4220 in its category [2] Fund Management - The fund manager of Anxin Medical Health Stock A is Chi Chenshen, who has been in the position for 4 years and 276 days, managing a total fund size of 946 million CNY [3] - During his tenure, the best fund return was 56.95%, while the worst return was 53.28% [3]

Core Viewpoint - Huakang Clean achieved a significant increase in stock price and trading volume, indicating strong market interest and potential growth in the medical purification system sector [1][2]. Group 1: Financial Performance - For the first half of 2025, Huakang Clean reported revenue of 835 million yuan, representing a year-on-year growth of 50.73% [2]. - The net profit attributable to the parent company reached 18.68 million yuan, showing a substantial increase of 273.48% compared to the previous year [2]. - Cumulative cash dividends since the company's A-share listing amount to 40.02 million yuan, with 29.46 million yuan distributed over the past three years [3]. Group 2: Shareholder and Market Activity - As of September 19, the number of Huakang Clean's shareholders decreased by 2.96% to 10,000, while the average circulating shares per person increased by 3.05% to 7,272 shares [2]. - On September 25, Huakang Clean's financing buy-in amounted to 20.90 million yuan, with a net financing purchase of 1.18 million yuan, indicating strong investor interest [1]. - The total financing and securities balance reached 62.02 million yuan, accounting for 1.67% of the circulating market value, which is above the 90th percentile of the past year [1]. Group 3: Business Overview - Huakang Clean, established on November 12, 2008, specializes in the research, design, implementation, and operation of medical purification systems, along with the sale of related medical equipment and consumables [1]. - The revenue composition of Huakang Clean includes 85.24% from purification system integration, 8.53% from medical consumables, 3.74% from medical equipment sales, and 1.88% from operation services [1]. Group 4: Institutional Holdings - As of June 30, 2025, notable institutional shareholders include Anxin Medical Health Stock A, which is the fifth largest shareholder with 652,800 shares, and Nuoan Multi-Strategy Mixed A, the tenth largest shareholder with 429,900 shares, both being new entrants [3].

Core Viewpoint - Huakang Clean's stock experienced a decline of 1.07% on September 15, with a trading volume of 129 million yuan, indicating a potential concern in market sentiment towards the company [1]. Financing and Trading Data - On September 15, Huakang Clean had a financing buy-in amount of 8.33 million yuan and a financing repayment of 10.36 million yuan, resulting in a net financing outflow of 2.03 million yuan [1]. - As of September 15, the total financing and securities lending balance for Huakang Clean was 59.11 million yuan, which represents 1.66% of its market capitalization and is above the 80th percentile of the past year, indicating a high level of financing activity [1]. - There were no shares sold or repaid in the securities lending market on September 15, with a securities lending balance of 0, which is above the 70th percentile of the past year, suggesting a lack of short-selling activity [1]. Company Overview - Huakang Clean, established on November 12, 2008, and listed on January 28, 2022, is located in Wuhan, Hubei Province. The company specializes in the research, design, implementation, and operation of medical purification systems, along with the sale of related medical equipment and consumables [1]. - The revenue composition of Huakang Clean includes 85.24% from purification system integration, 8.53% from medical consumables sales, 3.74% from medical equipment sales, 1.88% from operation and maintenance services, and 0.61% from other sources [1]. Financial Performance - For the first half of 2025, Huakang Clean reported a revenue of 835 million yuan, reflecting a year-on-year growth of 50.73%. The net profit attributable to the parent company was 18.68 million yuan, showing a significant increase of 273.48% compared to the previous year [2]. - Since its A-share listing, Huakang Clean has distributed a total of 40.02 million yuan in dividends, with 29.46 million yuan distributed over the past three years [3]. Shareholder Information - As of September 10, Huakang Clean had 10,300 shareholders, a decrease of 8.37% from the previous period, while the average number of circulating shares per shareholder increased by 9.14% to 7,056 shares [2]. - Notable institutional holdings include Anxin Medical Health Stock A as the fifth largest circulating shareholder with 652,800 shares, and Nuoan Multi-Strategy Mixed A as the tenth largest with 429,900 shares, both being new shareholders [3].

Group 1 - The core viewpoint of the news is that Huakang Clean has experienced a significant decline in stock price, with a 5.09% drop on September 4, leading to a cumulative decline of 11.04% over three consecutive days [1] - As of the report, Huakang Clean's stock price is at 31.90 yuan per share, with a trading volume of 1.23 billion yuan and a turnover rate of 5.10%, resulting in a total market capitalization of 34.38 billion yuan [1] - The company, established on November 12, 2008, specializes in the research, design, implementation, and operation of medical purification systems, with its main revenue sources being 85.24% from purification system integration, 8.53% from medical consumables sales, 3.74% from medical equipment sales, and 1.88% from operation and maintenance services [1] Group 2 - From the perspective of Huakang Clean's top ten circulating shareholders, Noan Fund's Noan Multi-Strategy Mixed A (320016) has entered the top ten, holding 429,900 shares, which is 0.84% of the circulating shares [2] - The estimated floating loss for Noan Multi-Strategy Mixed A today is approximately 735,200 yuan, with a total floating loss of 1.79 million yuan during the three-day decline [2] - Noan Multi-Strategy Mixed A has achieved a return of 54.4% this year, ranking 527 out of 8,180 in its category, and a return of 110.3% over the past year, ranking 244 out of 7,978 [2] Group 3 - The fund managers of Noan Multi-Strategy Mixed A are Kong Xianzheng and Wang Haichang, with Kong having a tenure of 4 years and 283 days and a best fund return of 68.36% during his tenure [3] - Wang Haichang has a tenure of 3 years and 45 days, with a best fund return of 56.51% during his time managing the fund [3]